BBM — Blueberries Medical Income Statement
0.000.00%
- CA$7.98m
- CA$7.37m
- CA$0.29m
Annual income statement for Blueberries Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.066 | 0.139 | 0.235 | 0.288 |
Cost of Revenue | |||||
Gross Profit | — | 0.062 | -0.245 | -0.018 | 0.084 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.8 | 4.19 | 5.19 | 1.78 | 1.82 |
Operating Profit | -10.8 | -4.12 | -5.05 | -1.55 | -1.54 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.8 | -4.94 | -5.15 | -1.47 | -1.64 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.8 | -4.94 | -5.15 | -1.47 | -1.64 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.8 | -4.94 | -5.15 | -1.47 | -1.64 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.8 | -4.94 | -5.15 | -1.47 | -1.64 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.062 | -0.04 | -0.012 | -0.01 | -0.007 |